Study to Evaluate SPI-1005 in Adults With Meniere's Disease
Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of three dose levels of SPI-1005 compared to
placebo on vertigo, tinnitus and sensorineural hearing loss in 40 adults with Meniere's
disease.